Company research
Guardant Health, Inc.
CIK 1576280Updated Nov 18, 2026
GH price & chart
Loading TradingView…
NASDAQ:GH on TradingView ↗About the company
Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer.
In the news
No coverage from other publishers is available.
Recent filings
4 filing
144 filing
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities · Other Events
Items 1.01, 2.03, 3.02, 8.01, 9.01
4 filing
4 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 1,276,786,000Source | 1,538,727,000Source | 1,912,294,000Source | 1,331,999,000Source | 1,609,340,000Source | 1,915,291,000Source | 1,344,226,000Source | 1,704,598,000Source | 2,013,659,000Source | 1,485,609,000Source | 1,786,421,000Source | 1,609,985,000Source |
| Property, Plant and Equipment, NetUSD | 124,609,000Source | 125,169,000Source | 155,299,000Source | 126,141,000Source | 132,317,000Source | 150,035,000Source | 129,294,000Source | 138,387,000Source | 145,915,000Source | 136,813,000Source | 145,096,000Source | 167,920,000Source |
| GoodwillUSD | 3,290,000Source | 3,290,000Source | 77,257,000Source | 3,290,000Source | 3,290,000Source | 77,257,000Source | 3,290,000Source | 3,290,000Source | 77,257,000Source | 3,290,000Source | 3,290,000Source | 3,290,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 5,477,000Source | 7,251,000Source | 25,267,000Source | 5,864,000Source | 7,742,000Source | 25,543,000Source | 6,280,000Source | 8,294,000Source | 25,921,000Source | 6,760,000Source | 8,979,000Source | 11,727,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 580,013,000Source | 585,022,000Source | 1,053,469,000Source | 629,143,000Source | 933,694,000Source | 989,291,000Source | 698,572,000Source | 1,029,027,000Source | 378,203,000Source | 525,540,000Source | 1,133,537,000Source | 141,647,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 115,585,000Source | 88,465,000Source | 144,249,000Source | 130,252,000Source | 100,519,000Source | 137,404,000Source | 115,426,000Source | 84,562,000Source | 137,849,000Source | 110,253,000Source | 88,783,000Source | 97,256,000Source |
| Inventory, NetUSD | 90,489,000Source | 72,298,000Source | 105,463,000Source | 84,061,000Source | 66,984,000Source | 83,851,000Source | 77,256,000Source | 62,991,000Source | 85,876,000Source | 71,083,000Source | 61,948,000Source | 51,598,000Source |
| Assets, CurrentUSD | 828,885,000Source | 1,226,715,000Source | 1,364,639,000Source | 883,432,000Source | 1,289,974,000Source | 1,367,505,000Source | 927,026,000Source | 1,308,546,000Source | 1,466,046,000Source | 1,055,114,000Source | 1,347,106,000Source | 1,191,594,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 42,798,000Source | 66,883,000Source | 61,458,000Source | 39,976,000Source | 87,232,000Source | 43,490,000Source | 35,772,000Source | 31,736,000Source | 40,723,000Source | 33,800,000Source | 27,741,000Source | 31,509,000Source |
| Operating Lease, Right-of-Use AssetUSD | 163,550,000Source | 144,964,000Source | 147,566,000Source | 169,768,000Source | 146,111,000Source | 153,906,000Source | 140,500,000Source | 151,881,000Source | 158,849,000Source | 142,265,000Source | 157,616,000Source | 174,001,000Source |
| Other Assets, NoncurrentUSD | 41,473,000Source | 31,338,000Source | 27,996,000Source | 37,167,000Source | 29,906,000Source | 28,895,000Source | 32,555,000Source | 94,200,000Source | 28,457,000Source | 37,152,000Source | 124,334,000Source | 61,453,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 1,631,259,000Source | 1,598,823,000Source | 2,135,161,000Source | 1,637,474,000Source | 1,610,953,000Source | 2,096,364,000Source | 1,595,015,000Source | 1,636,313,000Source | 2,112,966,000Source | 1,625,256,000Source | 1,627,737,000Source | 1,549,805,000Source |
| Stockholders’ equity: | ||||||||||||
| Additional Paid in CapitalUSD | 2,560,814,000Source | 2,410,416,000Source | 3,009,424,000Source | 2,516,550,000Source | 2,363,501,000Source | 2,930,665,000Source | 2,472,272,000Source | 2,329,930,000Source | 2,900,056,000Source | 2,443,788,000Source | 2,304,220,000Source | 1,742,114,000Source |
| Retained Earnings (Accumulated Deficit)USD | -2,866,018,000Source | -2,467,229,000Source | -3,226,729,000Source | -2,773,293,000Source | -2,359,475,000Source | -3,106,587,000Source | -2,673,394,000Source | -2,256,847,000Source | -2,994,512,000Source | -2,578,235,000Source | -2,141,862,000Source | -1,662,413,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -4,260,000Source | -3,284,000Source | -5,563,000Source | -3,723,000Source | -5,640,000Source | -5,152,000Source | -4,658,000Source | -4,799,000Source | -4,852,000Source | -5,201,000Source | -3,675,000Source | -19,522,000Source |
| Stockholders' Equity Attributable to ParentUSD | -354,473,000Source | -60,096,000Source | -222,867,000Source | -305,475,000Source | -1,613,000Source | -181,073,000Source | -250,789,000Source | 68,285,000Source | -99,307,000Source | -139,647,000Source | 158,684,000Source | 60,180,000Source |
| Liabilities and EquityUSD | 1,276,786,000Source | 1,538,727,000Source | 1,912,294,000Source | 1,331,999,000Source | 1,609,340,000Source | 1,915,291,000Source | 1,344,226,000Source | 1,704,598,000Source | 2,013,659,000Source | 1,485,609,000Source | 1,786,421,000Source | 1,609,985,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 236,919,000Source | 197,345,000Source | 338,962,000Source | 238,430,000Source | 201,569,000Source | 292,145,000Source | 225,753,000Source | 220,009,000Source | 302,730,000Source | 225,583,000Source | 205,917,000Source | 193,220,000Source |
| Operating Lease, Liability, CurrentUSD | 26,395,000Source | 27,383,000Source | 27,758,000Source | 26,277,000Source | 27,663,000Source | 28,030,000Source | 29,666,000Source | 27,957,000Source | 27,679,000Source | 29,213,000Source | 27,950,000Source | 21,878,000Source |
| Accounts Payable, CurrentUSD | 20,142,000Source | 15,473,000Source | 93,514,000Source | 44,802,000Source | 42,447,000Source | 75,034,000Source | 49,770,000Source | 37,603,000Source | 54,442,000Source | 38,551,000Source | 51,741,000Source | 68,911,000Source |
| Operating Lease, Liability, NoncurrentUSD | 185,387,000Source | 170,131,000Source | 166,312,000Source | 192,348,000Source | 172,194,000Source | 173,055,000Source | 160,378,000Source | 178,907,000Source | 178,463,000Source | 164,292,000Source | 185,848,000Source | 210,015,000Source |
| Other Liabilities, NoncurrentUSD | 94,359,000Source | 89,446,000Source | 126,944,000Source | 91,170,000Source | 95,934,000Source | 127,693,000Source | 92,545,000Source | 96,786,000Source | 127,773,000Source | 92,834,000Source | 96,006,000Source | 9,179,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 71,707,000Source | 71,671,000Source | 79,291,000Source | 71,011,000Source | 70,680,000Source | 78,013,000Source | 76,003,000Source | 67,211,000Source | 77,889,000Source | — | 187,952,000Source | — |
| Deferred Revenue, CurrentUSD | — | — | — | — | — | — | — | — | — | — | — | 17,403,000Source |
| Long-term DebtUSD | 1,114,594,000Source | — | 1,502,943,000Source | 1,115,526,000Source | — | 1,503,471,000Source | 1,116,339,000Source | — | 1,504,000,000Source | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | -107,754,000Source | — | — | — | -95,159,000Source | — | -436,373,000Source | -479,449,000Source | -654,588,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 9,442,000Source | 10,236,000Source | 39,736,000Source | 42,387,000Source | 42,881,000Source | 35,962,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 47,608,000Source | 37,757,000Source | 166,217,000Source | 140,411,000Source | 90,759,000Source | 94,685,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -942,000Source | 6,115,000Source | 28,175,000Source | 21,389,000Source | -8,378,000Source | -375,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -2,025,000Source | 6,173,000Source | 14,792,000Source | 9,135,000Source | 10,350,000Source | 20,926,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -1,705,000Source | 287,000Source | -541,000Source | -236,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -65,623,000Source | -62,689,000Source | -184,760,000Source | -239,858,000Source | -324,975,000Source | -309,463,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | 58,988,000Source | — | — | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 699,418,000Source | 302,864,000Source | -627,202,000Source | -261,308,000Source | 840,250,000Source | 149,816,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | — | — | — | — | — | — | — | — | — | — | -1,531,000Source | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 5,580,000Source | 4,459,000Source | 48,306,000Source | 35,085,000Source | 20,486,000Source | 77,461,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 20,650,000Source | 15,497,000Source | 30,535,000Source | 15,681,000Source | 11,197,000Source | 7,878,000Source |
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | 0Source | 45,010,000Source | 45,010,000Source | — | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -21,577,000Source | -66,850,000Source | 671,133,000Source | -996,000Source | 477,375,000Source | -189,093,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | — | — | — | — | — | -4,476,000Source | -3,000Source | 3,596,000Source | -153,000Source | 6,028,000Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 612,024,000Source | 174,098,000Source | -140,338,000Source | -503,932,000Source | 991,739,000Source | -350,340,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 689,515,000Source | 688,368,000Source | 1,167,739,000Source | 735,480,000Source | 1,101,441,000Source | 803,853,000Source | 489,417,000Source | 629,755,000Source | 1,133,687,000Source | 141,948,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 3,771,000Source | — | — | — |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 869,000Source | 1,007,000Source | 1,969,000Source | 1,331,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 42,808,000Source | 49,769,000Source | 57,725,000Source | 42,462,000Source | 47,608,000Source | 37,757,000Source | 166,217,000Source | 140,411,000Source | 90,759,000Source | 94,685,000Source |
| Amortization of Debt Issuance CostsUSD | — | — | 768,000Source | 645,000Source | 1,182,000Source | 764,000Source | 1,178,000Source | 702,000Source | 3,243,000Source | 2,581,000Source | 2,575,000Source | — |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | — | — | — | — | — | 2,569,000Source |
| Amortization of Intangible AssetsUSD | — | — | 400,000Source | 500,000Source | 300,000Source | 400,000Source | 400,000Source | 500,000Source | 1,700,000Source | 2,200,000Source | 2,700,000Source | 2,500,000Source |
| Debt Securities, Realized Gain (Loss)USD | — | — | 0Source | 0Source | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| DepreciationUSD | — | — | 9,000,000Source | 10,100,000Source | 9,300,000Source | 9,600,000Source | 9,100,000Source | 9,800,000Source | 38,100,000Source | 40,100,000Source | 40,000,000Source | 33,400,000Source |
| Equity Securities, FV-NI, Gain (Loss)USD | — | — | — | — | — | — | — | 0Source | 0Source | -44,401,000Source | — | — |
| Equity Securities, FV-NI, Unrealized Gain (Loss)USD | — | — | — | — | — | — | — | — | — | — | 79,710,000Source | -7,793,000Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | -99,785,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | 0Source | 13,672,000Source | 13,672,000Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 53,266,000Source | 49,129,000Source | 61,660,000Source | 50,259,000Source | 57,926,000Source | 46,952,000Source | 211,410,000Source | 180,123,000Source | 155,800,000Source | 163,956,000Source |
| GoodwillUSD | — | — | 3,290,000Source | 3,290,000Source | 77,257,000Source | 3,290,000Source | 77,257,000Source | 3,290,000Source | 77,257,000Source | 3,290,000Source | 3,290,000Source | 3,290,000Source |
| Income Tax Expense (Benefit)USD | — | — | 136,000Source | 30,000Source | 185,000Source | 38,000Source | 372,000Source | 290,000Source | -1,263,000Source | 1,284,000Source | 685,000Source | 1,139,000Source |
| InterestExpenseNonoperatingUSD | — | — | 943,000Source | 646,000Source | 1,346,000Source | 983,000Source | 1,347,000Source | 791,000Source | 3,897,000Source | 2,581,000Source | — | — |
| Investment Income, InterestUSD | — | — | 7,391,000Source | 13,257,000Source | 10,199,000Source | 7,560,000Source | 11,151,000Source | 9,112,000Source | 34,095,000Source | 53,691,000Source | 35,365,000Source | 6,069,000Source |
| Marketable Securities, Unrealized Gain (Loss)USD | — | — | — | — | — | — | — | — | — | — | — | -7,800,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -92,725,000Source | -107,754,000Source | -120,142,000Source | -99,899,000Source | -112,075,000Source | -95,159,000Source | -416,277,000Source | -436,373,000Source | -479,449,000Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -92,725,000Source | -107,754,000Source | -120,142,000Source | -99,899,000Source | -112,075,000Source | -95,159,000Source | -416,277,000Source | -436,373,000Source | -479,449,000Source | -654,588,000Source |
| Operating Lease, ExpenseUSD | — | — | 8,600,000Source | 8,100,000Source | 8,600,000Source | 8,600,000Source | 8,600,000Source | 7,900,000Source | 33,600,000Source | 31,100,000Source | 29,700,000Source | 28,600,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -48,000Source | -3,007,000Source | 308,000Source | -25,000Source | -157,000Source | 7,851,000Source | -10,490,000Source | -42,605,000Source | 53,174,000Source | -12,778,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | 257,128,000Source | 0Source | 493,116,000Source | 0Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | — | — | — | — | — | — | — | 307,323,000Source | 307,323,000Source | 35,000,000Source | 1,494,700,000Source | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 3,651,000Source | 768,000Source | 19,223,000Source | 3,119,000Source | 405,000Source | 2,625,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | — | — | — | — | — | — | —Source | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 265,196,000Source | 191,476,000Source | 334,978,000Source | 232,088,000Source | 301,665,000Source | 203,471,000Source | 982,021,000Source | 739,016,000Source | 563,948,000Source | 449,538,000Source |
| Cost of RevenueUSD | — | — | 93,587,000Source | 74,489,000Source | 115,949,000Source | 81,205,000Source | 104,919,000Source | 74,723,000Source | 349,007,000Source | — | — | — |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Income (Loss)USD | — | — | -98,989,000Source | -117,328,000Source | -129,118,000Source | -106,413,000Source | -121,350,000Source | -111,041,000Source | -437,248,000Source | -443,594,000Source | -564,725,000Source | -544,378,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -48,000Source | -3,007,000Source | 308,000Source | -25,000Source | -157,000Source | 7,851,000Source | -10,490,000Source | -42,605,000Source | 53,174,000Source | -12,778,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -92,589,000Source | -107,724,000Source | -119,957,000Source | -99,861,000Source | -111,703,000Source | -94,869,000Source | -417,540,000Source | -435,089,000Source | -478,764,000Source | -653,449,000Source |
| Income Tax Expense (Benefit)USD | — | — | 136,000Source | 30,000Source | 185,000Source | 38,000Source | 372,000Source | 290,000Source | -1,263,000Source | 1,284,000Source | 685,000Source | 1,139,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -92,725,000Source | -107,754,000Source | -120,142,000Source | -99,899,000Source | -112,075,000Source | -95,159,000Source | -416,277,000Source | -436,373,000Source | -479,449,000Source | — |
| Earnings Per Share, BasicUSD per share | — | — | -0.74Source | -0.88Source | -0.9Source | -0.8Source | -0.85Source | -0.77Source | -3.32Source | -3.56Source | -4.28Source | -6.41Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.74Source | -0.88Source | -0.9Source | -0.8Source | -0.85Source | -0.77Source | -3.32Source | -3.56Source | -4.28Source | -6.41Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 124,807,000Source | 123,051,000Source | 132,867,000Source | 124,114,000Source | 131,273,000Source | 123,871,000Source | 125,374,000Source | 122,745,000Source | 111,988,000Source | 102,178,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 124,807,000Source | 123,051,000Source | 132,867,000Source | 124,114,000Source | 131,273,000Source | 123,871,000Source | 125,374,000Source | 122,745,000Source | 111,988,000Source | 102,178,000Source |
| Interest Expense (non-operating)USD | — | — | 943,000Source | 646,000Source | 1,346,000Source | 983,000Source | 1,347,000Source | 791,000Source | 3,897,000Source | 2,581,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 400,000Source | 500,000Source | 300,000Source | 400,000Source | 400,000Source | 500,000Source | 1,700,000Source | 2,200,000Source | 2,700,000Source | 2,500,000Source |
| Costs and ExpensesUSD | — | — | 364,185,000Source | 308,804,000Source | 464,096,000Source | 338,501,000Source | 423,015,000Source | 314,512,000Source | 1,419,269,000Source | 1,182,610,000Source | 1,128,673,000Source | 993,916,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 442,000Source | 997,000Source | 1,226,000Source | 1,375,000Source |
| Debt Securities, Realized Gain (Loss)USD | — | — | 0Source | 0Source | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | -99,785,000Source |
| General and Administrative ExpenseUSD | — | — | 53,266,000Source | 49,129,000Source | 61,660,000Source | 50,259,000Source | 57,926,000Source | 46,952,000Source | 211,410,000Source | 180,123,000Source | 155,800,000Source | 163,956,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -413,482,000Source | -437,179,000Source | -481,405,000Source | -659,757,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 2,578,000Source | 2,577,000Source |
| Interest Expense, DebtUSD | — | — | 943,000Source | 645,000Source | 1,346,000Source | 983,000Source | 1,347,000Source | 791,000Source | 3,897,000Source | — | — | — |
| Investment Income, InterestUSD | — | — | 7,391,000Source | 13,257,000Source | 10,199,000Source | 7,560,000Source | 11,151,000Source | 9,112,000Source | 34,095,000Source | 53,691,000Source | 35,365,000Source | 6,069,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -92,725,000Source | -107,754,000Source | -120,142,000Source | -99,899,000Source | -112,075,000Source | -95,159,000Source | -416,277,000Source | -436,373,000Source | -479,449,000Source | -654,588,000Source |
| Operating Lease, ExpenseUSD | — | — | 8,600,000Source | 8,100,000Source | 8,600,000Source | 8,600,000Source | 8,600,000Source | 7,900,000Source | 33,600,000Source | 31,100,000Source | 29,700,000Source | 28,600,000Source |
| Other Cost and Expense, OperatingUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 83,400,000Source | — |
| Research and Development ExpenseUSD | — | — | 89,957,000Source | 87,306,000Source | 96,533,000Source | 87,449,000Source | 91,038,000Source | 88,521,000Source | 364,191,000Source | 347,753,000Source | 367,194,000Source | 373,807,000Source |
| Selling and Marketing ExpenseUSD | — | — | 127,375,000Source | 97,880,000Source | 189,954,000Source | 119,588,000Source | 169,132,000Source | 104,316,000Source | 494,661,000Source | 364,935,000Source | 295,227,000Source | 299,828,000Source |
Offerings
Registration 333-297841
Filing attachments
d128095dex41.htm · 8-K · 2026-11-16
Exhibit 4.1 EXECUTION VERSION GUARDANT HEALTH, INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of November 16, 2026 0% Convertible Senior Notes due 2032 TABLE OF CONTENTS Page Article 1. Definitions; Rules of Construction …
Read attachment ↗d128095dex991.htm · 8-K · 2026-11-16
Exhibit 99.1 Guardant Health Announces Proposed $500.0 Million Offering of Convertible Senior Notes Due 2032 PALO ALTO, Calif. November 11, 2026 - (BUSINESS WIRE) - Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced its intention to offer $500.0 million aggregate principal amount of convertible senior notes due 2032 (the “notes”) in a private offering (the “offering”) to persons reasonably believed to be qualified institutional buyers …
Read attachment ↗d128095dex992.htm · 8-K · 2026-11-16
Exhibit 99.2 Guardant Health Prices $500 Million Convertible Senior Notes Offering PALO ALTO, Calif. November 12, 2026 - (BUSINESS WIRE) - Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced the pricing of its offering of $500 million aggregate principal amount of 0% convertible senior notes due 2032 (the “notes”) in a private offering (the “offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule …
Read attachment ↗d173393dex991.htm · 8-K · 2026-11-03
Exhibit 99.1 NEWS RELEASE Kevin Sayer Joins Guardant Health Board of Directors PALO ALTO, Calif., - November 3, 2026 - Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the appointment of Kevin Sayer to its board of directors. Mr. Sayer is former CEO of Dexcom, Inc. and current Executive Chairman of the Dexcom board, with decades of strategic leadership experience in digital health technology. “We are excited to welcome Kevin Sayer to Guardant’s board,…
Read attachment ↗d121100dex42.htm · S-3ASR · 2026-07-30
Exhibit 4.2 GUARDANT HEALTH, INC. INDENTURE Dated as of ___________, 20___ U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION Trustee TABLE OF CONTENTS Page ARTICLE I. DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.1. Definitions 1 Section 1.2. Other Definitions …
Read attachment ↗d66171dex41.htm · 8-K · 2025-11-07
EX-4.1 3 d66171dex41.htm EX-4.1 EX-4.1 Exhibit 4.1 GUARDANT HEALTH, INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of November 7, 2025 0% Convertible Senior Notes due 2033 TABLE OF CONTENTS Page Article 1. Definitions; Rules of Co…
Read attachment ↗